4//SEC Filing
McDonough John 4
Accession 0000899243-19-004675
CIK 0001492674other
Filed
Feb 24, 7:00 PM ET
Accepted
Feb 25, 3:39 PM ET
Size
7.7 KB
Accession
0000899243-19-004675
Insider Transaction Report
Form 4
McDonough John
DirectorPresident & CEO
Transactions
- Award
Stock Option (Right to Buy)
2019-02-21+200,000→ 200,000 totalExercise: $3.72Exp: 2029-02-21→ Common Stock (200,000 underlying) - Award
Restricted Stock Units
2019-02-21+100,000→ 100,000 total→ Common Stock (100,000 underlying)
Footnotes (3)
- [F1]The stock option vests in 48 equal monthly installments commencing February 21, 2019.
- [F2]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- [F3]The restricted stock units vest in three equal annual installments commencing February 21, 2020.
Documents
Issuer
T2 Biosystems, Inc.
CIK 0001492674
Entity typeother
Related Parties
1- filerCIK 0001615937
Filing Metadata
- Form type
- 4
- Filed
- Feb 24, 7:00 PM ET
- Accepted
- Feb 25, 3:39 PM ET
- Size
- 7.7 KB